Zika Virus–Associated Cerebellitis with Complete Clinical Recovery
Author(s) -
Mónica Pachar,
Dimelza Araúz,
Nathan Gundacker,
José Antonio Suárez,
José Antonio Suárez,
Brechla Moreno,
Sandra López-Vergès,
Ana Belén Araúz
Publication year - 2018
Publication title -
american journal of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.015
H-Index - 151
eISSN - 1476-1645
pISSN - 0002-9637
DOI - 10.4269/ajtmh.18-0261
Subject(s) - zika virus , medicine , pediatrics , encephalitis , outbreak , ataxia , dengue fever , flavivirus , microcephaly , serology , acute disseminated encephalomyelitis , rash , virology , dermatology , immunology , virus , multiple sclerosis , antibody , psychiatry
Zika virus (ZIKV) was first detected in the Americas in Brazil in 2015, with a rapid spread to surrounding countries. In Panama, the outbreak began in November 2015 in an indigenous community located on the Caribbean side of the country. Zika virus is typically associated with a diffuse rash, fever, and conjunctivitis. It can rarely cause neurologic manifestations, most commonly microcephaly and Guillain-Barré syndrome. Encephalitis and acute encephalomyelitis are known complications, but ZIKV-associated cerebellitis has yet to be reported in the literature. Herein, we report a case of cerebellitis in a patient infected with ZIKV. This patient developed severe frontal headache and vertigo on the third day of illness, and dysarthria and ataxia on the fifth day. After 1 week of hospitalization, the patient completely recovered. The laboratory serological diagnosis was complicated because of the detection of antibodies against dengue, suggesting a secondary flavivirus infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom